Arguments about Sanofi’s Menactra clinical trials for children
Since Sanofi-Pasteur’s ‘Menactra,’ a competing product of the GSK’s top meningococcal meningitis vaccine in Korea, ‘Menveo,’ has been conducted for clinical trials to extend indications in regards to the age group, a rumor said the company is trying to extend the range of indications(age) for Men...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
